Daratumumab-containing Induction Effects on Stem Cells Mobilization, colLection and Engraftment in Newly Diagnosed Multiple MyelomA Patients.

NCT05835726 · clinicaltrials.gov ↗

COMPLETED

Status

188

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Daratumumab
Autologous Stem Cell Transplantation
Leukapheresis

Interventions

DRUG: Daratumumab

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS